Infra-red transillumination stereophotography of the iris in Fuchs's heterochromic cyclitis.

Infra-red transillumination stereophotography of the iris in Fuchs's heterochromic cyclitis.

The structural pattern of the iris in 13 patients with Fuchs's heterochromic cyclitis (FHC) was studied by infra-red transillumination stereophotography. All eyes with FHC showed atrophic changes of the iris. Extensive iris atrophy appeared as light, even translucence of the iris, associated in some cases with occasional dense small patches or pigment clumps. Moderate punctate, patchy or radiat...

Significance of goniohaemorrhage in heterochromic cyclitis.

Fuch's heterochromic cyclitis: new clues regarding pathogenesis.

UCHS HETEROCHROMIC CYCLITIS (FHC) IS A CHRONIC, typically unilateral anterior segment uveitis syndrome.1 It is usually painless with limited inflammation characterized by diffuse, scattered, small and mediumsized keratic precipitates with mild anterior chamber flare, minimal anterior chamber cells, and iris atrophy that leads to secondary, acquired heterochromia. Immunohistochemistry of iris bi...

Fuchs's heterochromic cyclitis: a simultaneous bilateral fluorescein angiographic study of the iris.

Twelve patients with Fuchs's heterochromic cyclitis (FHC) were studied with simultaneous bilateral flucrescein angiography of the iris. The flow began a little earlier in the contralateral iris in 4 cases, and simultaneously in both irides in 8 cases. The radial iris vessels were narrow in 7 eyes with FHC and in the contralateral eyes of 2 elderly patients and 1 patient with pigmentary retinal ...

Fuchs's heterochromic cyclitis in congenital ocular toxoplasmosis.

We report a follow-up after 25 years of a patient with a congenital bilateral ocular toxoplasmosis who developed Fuchs's heterochromic cyclitis in her left eye. Whether Toxoplasma gondii can cause the development of Fuchs's heterochromic cyclitis, as our case suggests, or whether the iridocyclitis is a secondary ocular response to other agents, is not yet clear.